Abstract:411 Objectives: Acute kidney injury (AKI) often complicates treatment outcomes of hospitalized patients, which manifests as decreased kidney glomerular filtration and results in toxic chemicals accumulating in blood. The pathogenesis of many AKI conditions has implicated reactive oxygen species (ROS) as a major factor. Ongoing research has shown that nanomaterials are superior to their small molecule counterparts due to the ability to control their biodistribution and intrinsic scavenging abilities. We found that selenium-doped carbon quantum dots localize in the kidneys of mice and eliminate ROS to treat and prevent AKI. Methods: Carbon quantum dots with high antioxidant capacity were prepared by doping selenium (SeCQDs) through a hydrothermal treatment. PET imaging of SeCQDs was preformed to evaluate biodistribution using Zr-89 (half life: 78.4 h) after functionalizing with deferoxamine (DFO; 89Zr-DFO-SeCQDs). AKI was induced by intramuscular injection of 50% glycerol into the hindlimbs (8 mL/kg) as well as by intraperitoneal injection of cisplatin (20 mg/kg) in mice. An equivalent dose of amifostine, an FDA approved drug that acts through a similar mechanism for AKI treatment, was used to demonstrate the superiority of SeCQDs for AKI therapy. Results: SeCQDs were found to rapidly and exclusively accumulate in kidneys as the uptake was 25.37±4.51 %ID/g at 4 h post-injection (p.i.) following intravenous administration and up to 72 h p.i. (20.47 %ID/g) using PET imaging (n=3). Blood serum creatinine (CRE) and blood urea nitrogen (BUN) as well as H&E staining of kidney tissue were used to validate therapeutic effects in the AKI models. Therapeutic doses of SeCQDs were found to be 1 µg per mouse for AKI induced using 50% glycerol. Serum CRE and BUN were markedly lower for SeCQDs (0.38±0.08 and 44.2±11.7 mg/dL, respectively) compared to PBS negative controls (1.76±0.42 and 169.2±55.1 mg/dL, respectively) (n=5 for all groups). Moreover, cisplatin-induced AKI was prevented by administering 50 µg of SeCQDs per mouse as determined by serum CRE and BUN for SeCQDs (0.5±0.07 and 93.4±53.3 mg/dL, respectively) compared to PBS negative controls (2.24±0.4 and 199.2±36.4 mg/dL, respectively) (n=5 for all groups). Amifostine at an equivalent dose in each AKI model (based on selenium and sulfur composition) was ineffective to treat either glycerol- (BUN: 129.4±45 mg/dL, CRE: 1.06±0.4 mg/dL) or cisplatin-induced AKI (BUN: 174±24.3 mg/dL, CRE: 2±0.59 mg/dL) (n=5 for all groups). Conclusion: PET imaging elucidated that SeCQDs predominately accumulate in kidneys for as long as 72 h. The high renal accumulation of SeCQDs proved a highly effective therapy for the treatment of AKI induced using 50% glycerol and prevention of AKI from cisplatin due to its antioxidant properties. In the same animal models, amifostine was unsuccessful in AKI treatment and demonstrates the promise of utilizing nanomaterials over small molecule drugs to treat kidney diseases.

Renal-Accumulating Selenium-Doped Carbon Quantum Dots Treat Acute Kidney Injury in Mice

Selenium‐Doped Carbon Quantum Dots Act as Broad‐Spectrum Antioxidants for Acute Kidney Injury Management

Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway

Porous Se@SiO2 Nanospheres Attenuate Ischemia/reperfusion (I/r)-Induced Acute Kidney Injury (AKI) and Inflammation by Antioxidative Stress.

Polyacrylic Acid‐Coated Selenium‐Doped Carbon Dots Inhibit Ferroptosis to Alleviate Chemotherapy‐Associated Acute Kidney Injury

Phenylenediamine-Based Carbon Nanodots Alleviate Acute Kidney Injury Via Preferential Renal Accumulation and Antioxidant Capacity.

SOD Mineralized Zeolitic Imidazole Framework-8 for the treatment of chemotherapy-related acute kidney injury

Biodegradable Nanodots: Biodegradable Self‐Assembled Ultrasmall Nanodots As Reactive Oxygen/Nitrogen Species Scavengers for Theranostic Application in Acute Kidney Injury (small 8/2021)

Nephroprotective Role of Selenium Nanoparticles Against Glycerol-Induced Acute Kidney Injury in Rats

Selenium nanoparticles alleviate renal ischemia/reperfusion injury by inhibiting ferritinophagy via the XBP1/NCOA4 pathway

Simultaneous Elimination of Reactive Oxygen Species and Activation of Nrf2 by Ultrasmall Nanoparticles to Relieve Acute Kidney Injury

Renal Clearable Quantum Dot-Drug Conjugates Modulate Labile Iron Species and Scavenge Free Radicals for Attenuating Chemotherapeutic Drug-Induced Acute Kidney Injury

Porous Se@SiO2 Nanospheres Attenuate Cisplatin-Induced Acute Kidney Injury Via Activation of Sirt1.

Using Green Biosynthesized Lycopene-Coated Selenium Nanoparticles to Rescue Renal Damage in Glycerol-Induced Acute Kidney Injury in Rats

Molybdenum-based Nanoclusters Act As Antioxidants and Ameliorate Acute Kidney Injury in Mice

Ultrasmall Black Phosphorus Quantum Dots with Robust Antioxidative Properties for Acute Kidney and Liver Injury Therapy

Sodium selenite attenuates inflammatory response and oxidative stress injury by regulating the Nrf2/ARE pathway in contrast-induced acute kidney injury in rats

Multifunctional Nanosystem Based on Ultrasmall Carbon Dots for the Treatment of Acute Kidney Injury

The Reversal of Cisplatin-Induced Nephrotoxicity by Selenium Nanoparticles Functionalized with 11-Mercapto-1-undecanol by Inhibition of ROS-mediated Apoptosis.

Functionalized Selenium Nanoparticles with Nephroprotective Activity, the Important Roles of ROS-mediated Signaling Pathways.

Reactive Oxygen Species-Scavenging Mesoporous Poly(tannic acid) Nanospheres Alleviate Acute Kidney Injury by Inhibiting Ferroptosis